| Literature DB >> 24039797 |
Caixia Dong1, Pengfei Ge, Xiaolan Ren, Jie Wang, Haoqiang Fan, Xiang Yan, Shi-an Yin.
Abstract
OBJECTIVE: To prospectively evaluate the efficiency of daily providing complementary food supplements decreasing malnutrition and anemia prevalence in elder infants and young children living in areas affected by Wenchuan Earthquake.Entities:
Mesh:
Year: 2013 PMID: 24039797 PMCID: PMC3767697 DOI: 10.1371/journal.pone.0072711
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
The body weight (kg) and length (cm) of each group at the basal line.
| Age | Total | Boys | Girls | ||||||
| (m) | n | Length | weight | n | Length | weight | n | Length | Weight |
| 6∼ | 112 | 69.2±3.6 | 8.3±1.2 | 58 | 70.4±2.6 | 8.7±1.2 | 54 | 67.8±4.0 | 7.9±1.1 |
| 12∼ | 89 | 76.4±3.3 | 9.6±1.2 | 40 | 77.9±3.1 | 10.1±1.0 | 49 | 75.2±2.9 | 9.2±1.1 |
| 18∼24 | 112 | 80.7±4.2 | 10.2±1.2 | 56 | 82.0±3.9 | 10.7±1.2 | 55 | 79.3±4.1 | 9.7±1.0 |
The results were expressed as Mean±SD.
Figure 1The effect of given the complementary food supplements on prevalence of malnutrition.
Wasting (WLZ←2), stunting (LAZ←2) and underweight (WAZ←2).
Figure 2The effect of complementary food supplements on prevalence of anemia in the groups aged 6 months∼, 12 months ∼, and 12∼24 months.
The change of Z-score of infants and young children at different monitoring time point after given complementary food supplements.
| Monitoring | Total | Boys | Girls | |||||||||
| time point | n | WLZ | LAZ | WAZ | n | WLZ | LAZ | WAZ | n | WLZ | LAZ | WAZ |
| Infants aged 6–12 months | ||||||||||||
| Baseline | 114 | 0.23±1.14ab | −0.46±0.09a | −0.09±1.11a | 58 | 0.22±1.26a | −0.48±0.98a | −0.11±1.21a | 56 | 0.24±1.00ab | −0.44±0.88a | −0.06±1.00ab |
| 6 month | 65 | 0.06±0.93a | −0.08±1.15b | −0.05±1.01ab | 29 | 0.04±1.08a | 0.07±1.17b | 0.03±1.08ab | 36 | 0.07±0.81a | −0.19±1.13a | −0.12±0.96b |
| 12 months | 68 | 0.36±0.90b | −0.25±1.31ab | 0.10±1.19b | 39 | 0.26±1.02a | −0.42±1.36ab | −0.12±1.31ab | 29 | 0.49±0.72b | 0.00±1.22a | 0.38±0.96c |
| 18 months | 58 | 0.44±0.87b | −0.04±1.06b | 0.32±0.95c | 34 | 0.47±1.04a | 0.04±1.26b | 0.41±1.17b | 24 | 0.40±0.55ab | −0.16±0.71a | 0.19±0.47abc |
| Young children aged 12–18 months | ||||||||||||
| Baseline | 111 | −0.08±0.96abc | −0.35±1.08a | −0.22±0.98abc | 53 | −0.12±0.96ab | −0.23±1.17a | −0.21±0.96a | 58 | −0.04±0.97ab | −0.45±1.00ab | −0.24±1.00abc |
| 6 month | 87 | −0.36±1.01ab | −0.25±1.19a | −0.38±0.97ab | 47 | −0.32±1.03a | −0.30±1.02a | −0.38±1.04a | 40 | −0.40±1.01a | −0.20±1.38ab | −0.37±0.88ac |
| 12 months | 89 | −0.18±0.97b | −0.51±1.01a | −0.36±0.96b | 39 | −0.11±1.09ab | −0.41±0.97a | −0.26±1.00a | 50 | −0.23±0.86ab | −0.59±1.05a | −0.44±0.93c |
| 18 months | 92 | 0.17±0.90c | −0.26±1.40a | 0.00±1.00c | 43 | 0.25±0.92b | −0.47±1.60a | −0.04±1.10 a | 49 | 0.10±0.89b | −0.08±1.18b | 0.04±0.92b |
| Young children aged 18–24 months | ||||||||||||
| Baseline | 89 | −0.34±0.99a | −1.04±1.20a | −0.76±0.86a | 43 | −0.17±1.02a | −0.79±1.09a | −0.50±0.83a | 46 | −0.50±0.95a | −1.28±1.27a | −1.00±0.84a |
| 6 month | 75 | −0.33±0.93ab | −0.57±1.11b | −0.52±0.86ab | 45 | −0.43±0.88a | −0.52±1.06a | −0.58±0.79a | 30 | −0.18±1.01ab | −0.64±1.19b | −0.43±0.95b |
| 12 months | 79 | −0.04±0.88a | −0.70±0.85b | −0.37±0.89b | 46 | −0.15±0.85a | −0.63±0.85a | −0.42±0.84a | 33 | 0.11±0.93b | −0.79±0.85b | −0.30±0.95b |
| 18 months | 92 | −0.09±1.04ab | −0.47±1.27b | −0.28±0.99b | 46 | −0.08±1.21a | −0.45±1.42a | −0.28±1.11a | 46 | −0.10±0.84b | −0.48±1.10b | −0.29±0.85b |
The results were expressed as means ± SD. Means in the same age group within same column with different superscripts a–c were significantly different as a result of intervention at the P<0.05 level.
Hemoglobin concentration change of infants and young children at different monitoring time point after given the complementary food supplements (g/L).
| Monitoring time point | Total | Boys | Girls | |||
| n | Average | n | Average | n | Average | |
| Infants aged 6–12 months | ||||||
| Baseline | 114 | 104.4±12.6a | 58 | 103.1±1.36a | 56 | 105.8±11.4a |
| 6 month | 66 | 118.5±12.6b | 29 | 120.7±11.4b | 37 | 116.8±13.3b |
| 12 months | 68 | 114.3±9.4c | 39 | 113.7±7.0c | 29 | 115.1±11.9b |
| 18 months | 58 | 113.3±14.0c | 34 | 110.9±13.4c | 24 | 116.6±14.4b |
| Young children aged 12–18 months | ||||||
| Baseline | 111 | 104.7±12.7a | 53 | 107.8±12.0a | 58 | 101.8±12.8a |
| 6 month | 87 | 119.0±12.9b | 47 | 118.6±13.0b | 40 | 119.5±12.9b |
| 12 months | 89 | 118.0±9.3b | 39 | 118.4±9.9b | 50 | 117.6±8.8bc |
| 18 months | 92 | 115.2±9.0c | 43 | 116.0±9.0b | 49 | 114.6±9.0c |
| Young children aged 18–24 months | ||||||
| Baseline | 89 | 110.3±12.1a | 43 | 113.4±12.7a | 46 | 107.4±10.8a |
| 6 month | 75 | 119.3±14.8b | 45 | 121.4±14.6b | 30 | 116.2±14.7b |
| 12 months | 79 | 119.4±9.3b | 46 | 118.3±9.0b | 33 | 120.8±9.5b |
| 18 months | 92 | 120.5±11.9b | 45 | 119.2±11.5b | 46 | 121.7±12.3b |
The results were expressed as means ± SD. Means in the same age group within same column with different superscripts a–c were significantly different as a result of intervention at the P<0.05 level.